Highlights and Quick Summary
- Net Income Common for the quarter ending September 30, 2022 was $-13.7 Million (a -13.43% decrease compared to previous quarter)
- Year-over-year quarterly Net Income Common increased by 3.14%
- Annual Net Income Common for 2021 was $-43.2 Million (a 37.67% increase from previous year)
- Annual Net Income Common for 2020 was $-31.4 Million (a 2.03% increase from previous year)
- Annual Net Income Common for 2019 was $-30.7 Million (a 17.43% increase from previous year)
- Twelve month Net Income Common ending September 30, 2022 was $-58.4 Million (a 3.89% increase compared to previous quarter)
- Twelve month trailing Net Income Common increased by 35.29% year-over-year
Trailing Net Income Common for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $-58.4 Million | $-56.2 Million | $-51.8 Million | $-43.2 Million |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Income Common of Biodesix, Inc.
Most recent Net Income Commonof BDSX including historical data for past 10 years.Interactive Chart of Net Income Common of Biodesix, Inc.
Biodesix, Inc. Net Income Common for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-13.7 | $-15.82 | $-15.59 | – |
| 2021 | $-13.28 | $-11.51 | $-11.4 | $-6.96 | $-43.16 |
| 2020 | $-4.53 | $-8.85 | $-8.27 | $-9.71 | $-31.35 |
| 2019 | – | – | $-6.53 | $-9.6 | $-30.73 |
| 2018 | – | – | – | – | $-26.17 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research